Starting in 2027, health plans would cover certain home blood pressure monitors and limit opioid-first rules for pain medicine; pharmacists may dispense two medicines under board procedures.
Maternity health plans would cover a prescribed home blood pressure monitor and training when medically appropriate for pregnancy or the first year after birth.
Health plans could not deny nonopioid pain medicine in favor of opioids, require an opioid trial first, or charge more for the nonopioid medicine.
Pharmacists may provide ivermectin or hydroxychloroquine without a prescription under board approved procedures and warning labels, with secure storage and controlled access.
Health plans must cover prescribed home blood pressure devices and setup and use training. This applies to pregnant women and women within twelve months after giving birth who have maternity coverage. Coverage applies only when medically appropriate under professional guidelines. A device or training can be prescribed again only if the monitored condition worsens enough to need it or for a later pregnancy. Applies to plans issued, renewed, or continued on or after January 1, 2027.
Health plans may not favor opioid medicine over prescribed nonopioid medicine for pain. This applies when a licensed health professional prescribes nonopioid medicine for acute or chronic pain to a plan enrollee. For acute pain, the rule applies only when multiple nonopioid medicines are approved and indicated; the same condition applies separately to chronic pain. Applies to plans issued, renewed, or continued on or after January 1, 2027.
Pharmacists may dispense ivermectin and hydroxychloroquine without a prescription under board procedures. This applies to pharmacists dispensing these two medicines without a prescription. The board must approve a warning label and written procedures or protocols for use and indications. The drugs must be kept securely behind the counter and dispensed by a pharmacist or supervised pharmacy technician.
No hearings or votes scheduled.